Progression From Presymptomatic to Clinical Type 1 Diabetes After COVID-19 Infection
The incidence of type 1 diabetes increased during the COVID-19 pandemic. Temporal relationships between COVID-19 infection and the incidence of type 1 diabetes as well as the development of islet autoimmunity are reported. It remains unknown whether COVID-19 infection accelerates disease progression in children with preexisting islet autoimmunity. The study examined whether there is an association between COVID-19 infection and progression to clinical diabetes in youth with presymptomatic type 1 diabetes.
Contenu Associé
COVID-19 sévère et maladies auto-immunes ou inflammatoires incidentes : une étude épidémiologique nationale à partir des données du PMSI en 2020
6 déc. 2022
- COVID-19 et L'auto-immunité